ACHN Stock Soars 70% Following Acquisition By Alexion Pharmaceuticals
ACHN stock has gained 70% today after it was announced that Alexion Pharmaceuticals (NASDAQ:ALXN) would acquire Achillion Pharmaceuticals (NASDAQ:ACHN) in a deal worth $930 million USD. Alexion to Pay 73% Premium on ACHN Stock In a ... [Read]
ACHN Stock Zooms 17% as FDA Grants BTD for Danicopan
ACHN stock is leading in the biotech sector after Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that the FDA has granted Breakthrough Therapy Designation (BTD) for danicopan (ACH-4471). Investors Cheer the News When a pharmaceutical company releases ... [Read]
ACHN Stock Extends Rally: Soars 55% in 2 Sessions
ACHN stock has been on a roll for two days straight after Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced positive updates from the Phase 1 study of its product ACH-5228, an experimental oral factor D inhibitor. ACHN ... [Read]